AAAAAA

   
Results: 1-8 |
Results: 8
EFFICACY OF SOME POLYCHEMOTHERAPY PROGRAMS IN THE TREATMENT OF PATIENTS WITH MULTIPLE-MYELOMA
Authors: BESSMELTSEV SS ABDULKADYROV KM RUKAVITSYN OA
Citation: Ss. Bessmeltsev et al., EFFICACY OF SOME POLYCHEMOTHERAPY PROGRAMS IN THE TREATMENT OF PATIENTS WITH MULTIPLE-MYELOMA, Terapevticeskij arhiv, 70(7), 1998, pp. 46-49
HEPARIN IN THE TREATMENT OF HYPERVISCOSITY SYNDROME IN PATIENTS WITH MULTIPLE-MYELOMA (MM)
Authors: BESSMELTSEV SS ABDULKADYROV KM KATSADZE YL RUKAVITSYN OA
Citation: Ss. Bessmeltsev et al., HEPARIN IN THE TREATMENT OF HYPERVISCOSITY SYNDROME IN PATIENTS WITH MULTIPLE-MYELOMA (MM), Thrombosis and haemostasis, 1997, pp. 179-179
THE ROLE OF INVESTIGATIONS OF GLYCOSAMINO GLYCANES OF PERIPHERAL-BLOOD LEUKOCYTES IN DIAGNOSIS OF CHRONIC MYELOID-LEUKEMIA PHASES
Authors: KHARCHENKO MF BESSMELTSEV SS RUKAVITSYN OA ABDULKADYROV KM BITYUKOVA ES BLINOV MN
Citation: Mf. Kharchenko et al., THE ROLE OF INVESTIGATIONS OF GLYCOSAMINO GLYCANES OF PERIPHERAL-BLOOD LEUKOCYTES IN DIAGNOSIS OF CHRONIC MYELOID-LEUKEMIA PHASES, Terapevticeskij arhiv, 69(7), 1997, pp. 21-26
TREATMENT OF PATIENTS WITH MULTIPLY MYELOMA (MM) AND CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH ALPHA-2 INTERFERON (IFN)
Authors: BESSMELTSEV SS RUKAVITSYN OA ABDULKADYROV KM
Citation: Ss. Bessmeltsev et al., TREATMENT OF PATIENTS WITH MULTIPLY MYELOMA (MM) AND CHRONIC MYELOGENOUS LEUKEMIA (CML) WITH ALPHA-2 INTERFERON (IFN), Experimental hematology, 24(9), 1996, pp. 711-711
MORPHOLOGICAL STRUCTURAL CHARACTERISTICS OF HEMATOPOIETIC MICROENVIRONMENT IN PATIENTS WITH MULTIPLE-MYELOMA
Authors: ABDULKADYROV KM RUKAVITSYN OA BESSMELTSEV SS RUGAL VI
Citation: Km. Abdulkadyrov et al., MORPHOLOGICAL STRUCTURAL CHARACTERISTICS OF HEMATOPOIETIC MICROENVIRONMENT IN PATIENTS WITH MULTIPLE-MYELOMA, Gematologia i transfuziologia, 41(1), 1996, pp. 13-16
VERIFICATION OF CHRONIC MYELOID-LEUKEMIA - IS IT OBLIGATORY
Authors: ABDULKADYROV KM RUKAVITSYN OA BESSMELTSEV SS MARTYNKEVICH IS SALTYKOVA LB SIDOROVA ZY BLINOV MN SCHERBAKOVA EG SHILOVA ER
Citation: Km. Abdulkadyrov et al., VERIFICATION OF CHRONIC MYELOID-LEUKEMIA - IS IT OBLIGATORY, Terapevticeskij arhiv, 68(7), 1996, pp. 27-31
REAFERON (ALPHA(2)-INTERFERON) INTRODUCTI ON IN THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA
Authors: ABDULKADYROV KM MOISEEV SI SCHERBAKOVA YG BALASHOVA VA GLAZANOVA TV RUKAVITSYN OA MARTYNKEVICH IS GRITSAEV SV BLINOV MN
Citation: Km. Abdulkadyrov et al., REAFERON (ALPHA(2)-INTERFERON) INTRODUCTI ON IN THE TREATMENT OF CHRONIC MYELOID-LEUKEMIA, Terapevticeskij arhiv, 67(6), 1995, pp. 59-63
MARROW IN CHRONIC MYELOID-LEUKEMIA PATIEN TS - MORPHOFUNCTIONAL EFFECTS OF INTERFERON-ALPHA-2
Authors: ABDULKADYROV KM RUKAVITSYN OA MOISEEV SI RUGAL VI
Citation: Km. Abdulkadyrov et al., MARROW IN CHRONIC MYELOID-LEUKEMIA PATIEN TS - MORPHOFUNCTIONAL EFFECTS OF INTERFERON-ALPHA-2, Gematologia i transfuziologia, 38(3), 1993, pp. 11-13
Risultati: 1-8 |